Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
GH - Guardant Health Inc - Stock Price Chart
TickerGH [NASD, RUT]
CompanyGuardant Health Inc
IndustryDiagnostics & Research
Market Cap3.12BEPS (ttm)-3.92
P/E-EPS this Y25.79%
Forward P/E-EPS next Y12.59%
PEG-EPS past 5Y-8.88%
P/S5.17EPS next 5Y29.20%
P/B45.52EPS Q/Q27.37%
Dividend-Sales Q/Q30.90%
Insider Own5.21%Inst Own93.59%
Insider Trans-0.06%Inst Trans1.89%
Short Float9.28%EarningsMay 09/a
Analyst Recom1.39Target Price36.44
Avg Volume2.25M52W Range15.81 - 41.06
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chudova DaryaChief Technology OfficerMay 15 '24Option Exercise0.008,705046,106May 16 06:12 PM
EAGLE CRAIGChief Medical OfficerMay 15 '24Option Exercise0.003,717015,169May 16 06:14 PM
Tariq MusaDirectorMay 15 '24Option Exercise0.0025003,497May 16 06:17 PM
POTTER MYRTLE SDirectorMay 15 '24Option Exercise0.006907,651May 16 06:15 PM
Joyce Meghan V.DirectorMay 04 '24Option Exercise0.006604,654May 06 05:06 PM
AGEN - Agenus Inc - Stock Price Chart
CompanyAgenus Inc
Market Cap286.02MEPS (ttm)-12.62
P/E-EPS this Y35.33%
Forward P/E-EPS next Y2.78%
PEG-EPS past 5Y13.79%
P/S1.77EPS next 5Y-
P/B-EPS Q/Q29.41%
Dividend-Sales Q/Q22.28%
Insider Own4.96%Inst Own49.78%
Insider Trans92.32%Inst Trans-
Short Float15.71%EarningsMay 07/b
Analyst Recom1.20Target Price44.25
Avg Volume739.49K52W Range4.78 - 42.60
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMEN GARO HSee RemarksFeb 15 '24Buy0.65500,000324,050625,969Feb 15 06:59 PM
WIINBERG ULFDirectorNov 15 '23Buy0.7625,00019,000124,063Nov 17 04:22 PM
AGENUS INC10% OwnerOct 16 '23Buy1.1042947221,772,863Oct 16 05:49 PM
AGENUS INC10% OwnerOct 13 '23Buy1.1019,37321,31021,772,434Oct 16 05:49 PM
AGENUS INC10% OwnerOct 12 '23Buy1.103,1733,48821,753,061Oct 16 05:49 PM
BTM - Bitcoin Depot Inc - Stock Price Chart
TickerBTM [NASD]
CompanyBitcoin Depot Inc
IndustryCapital Markets
Market Cap35.72MEPS (ttm)-0.90
P/E-EPS this Y107.41%
Forward P/E6.69EPS next Y662.50%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B-EPS Q/Q-1229.27%
Dividend-Sales Q/Q-
Insider Own70.81%Inst Own31.05%
Insider Trans-20.43%Inst Trans12.52%
Short Float5.94%EarningsMay 14/b
Analyst Recom1.50Target Price4.56
Avg Volume203.66K52W Range1.36 - 10.75
Bitcoin Depot Inc. engages in converting cash into crypto currency. It offers payments, spending, and investing space through its kiosks and BDCheckout product. The company was founded by Brandon Mintz in July 2016 and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mintz Brandon TaylorSee RemarksMay 07 '24Sale1.7642,87575,443646,702May 08 08:40 PM
Buchanan Christopher ScottChief Operating OfficerMay 07 '24Sale1.8312,87523,515331,276May 08 08:45 PM
Mintz Brandon TaylorSee RemarksMay 06 '24Sale1.917,12513,601689,577May 08 08:40 PM
Buchanan Christopher ScottChief Operating OfficerMay 06 '24Sale1.907,12513,565344,151May 08 08:45 PM
Buchanan Christopher ScottChief Operating OfficerApr 29 '24Sale1.7550,00087,655351,276May 01 07:29 PM
BACK - IMAC Holdings Inc - Stock Price Chart
CompanyIMAC Holdings Inc
IndustryMedical Care Facilities
Market Cap3.83MEPS (ttm)-13.61
P/E-EPS this Y57.26%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y10.09%
P/S0.45EPS next 5Y-
P/B-EPS Q/Q94.42%
Dividend-Sales Q/Q-100.00%
Insider Own17.94%Inst Own13.69%
Insider Trans0.00%Inst Trans-
Short Float16.16%Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume979.52K52W Range1.22 - 7.75
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Franklin, TN.
BYRN - Byrna Technologies Inc - Stock Price Chart
CompanyByrna Technologies Inc
IndustryAerospace & Defense
Market Cap275.38MEPS (ttm)-0.27
P/E-EPS this Y62.16%
Forward P/E201.83EPS next Y142.86%
PEG-EPS past 5Y-10.39%
P/S5.41EPS next 5Y-
P/B6.23EPS Q/Q100.71%
Dividend-Sales Q/Q98.00%
Insider Own22.98%Inst Own32.62%
Insider Trans-0.56%Inst Trans-3.87%
Short Float5.83%EarningsApr 05/b
Analyst Recom1.00Target Price16.62
Avg Volume250.50K52W Range2.19 - 15.34
Byrna Technologies, Inc. is a less-lethal self-defense technology company, which engages in the business of developing, manufacturing, and selling innovative less-lethal personal security solutions. It operates through the following geographical segments: the United States, South Africa, Europe, South America, and Asia, and Canada. The company was founded on March 1, 2005 and is headquartered in Andover, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hughes HerbertChairman of the BoardMay 21 '24Sale11.168,83698,584128,589May 21 08:00 PM
Wager LisaCorporate Secretary, CGOMay 21 '24Sale11.218,33393,407257,887May 21 08:02 PM
North DavidChief Financial OfficerApr 25 '24Option Exercise9.235,83453,84871,234Apr 29 08:00 PM
Wager LisaCorporate Secretary, CGOMar 07 '24Option Exercise1.9033,63163,899224,317Mar 08 08:39 AM
Wager LisaCorporate Secretary, CGOFeb 21 '24Sale11.487,07281,211190,686Feb 23 08:01 PM
OLB - OLB Group Inc - Stock Price Chart
TickerOLB [NASD]
CompanyOLB Group Inc
IndustrySoftware - Infrastructure
Market Cap6.84MEPS (ttm)-14.95
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-42.88%
P/S0.25EPS next 5Y-
P/B0.62EPS Q/Q21.32%
Dividend-Sales Q/Q-47.21%
Insider Own39.81%Inst Own3.33%
Insider Trans167.27%Inst Trans-
Short Float1.60%EarningsApr 15/b
Analyst Recom1.00Target Price30.00
Avg Volume33.19K52W Range2.84 - 11.70
The OLB Group, Inc. is a FinTech company, which focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. It operates through the Fintech Services and Bitcoin Mining Business segments. The Fintech Services segment provides integrated financial and transaction processing services to businesses throughout the United States. The company was founded by Ronny Yakov on November 18, 2004 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YAKOV RONNYChairman and CEOJan 16 '24Buy0.77784,212600,0015,409,701Jan 19 01:57 PM
Smith Patrick GVice PresidentJan 16 '24Buy0.77392,106300,000642,929Jan 19 11:16 AM
YAKOV RONNYChairman and CEOJan 12 '24Option Exercise0.00420,001425,829,702Jan 26 06:02 PM
Smith Patrick GVice President - FinanceJan 12 '24Option Exercise0.00381,069381,023,998Jan 30 04:10 PM
YAKOV RONNYChairman and CEOJul 21 '23Buy0.998,1158,0524,625,489Dec 12 06:14 AM
NCPL - Netcapital Inc - Stock Price Chart
CompanyNetcapital Inc
IndustryCapital Markets
Market Cap3.85MEPS (ttm)-0.07
P/E-EPS this Y-142.86%
Forward P/E-EPS next Y70.37%
PEG-EPS past 5Y8.51%
P/S0.50EPS next 5Y-
P/B0.08EPS Q/Q-159.17%
Dividend-Sales Q/Q-53.87%
Insider Own17.79%Inst Own15.46%
Insider Trans7.21%Inst Trans30.03%
Short Float0.26%EarningsMar 18/a
Analyst Recom1.00Target Price0.20
Avg Volume5.07M52W Range0.11 - 1.65
Netcapital, Inc. is a fintech company, which engages in the provision of financial solutions. The firm's platform allows private companies to raise capital online and provides private equity investment opportunities to investors. The company was founded by Sean F. Lee on April 25, 1984 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Geary Steven FDirectorApr 24 '24Buy0.13239,27431,680249,574Apr 25 08:44 PM
STEP - StepStone Group Inc - Stock Price Chart
CompanyStepStone Group Inc
IndustryAsset Management
Market Cap2.74BEPS (ttm)0.92
P/E45.46EPS this Y42.48%
Forward P/E19.45EPS next Y24.41%
PEG2.79EPS past 5Y-13.21%
P/S3.85EPS next 5Y16.30%
P/B8.43EPS Q/Q9.39%
Dividend2.78%Sales Q/Q102.10%
Insider Own15.15%Inst Own83.91%
Insider Trans-5.40%Inst Trans-4.13%
Short Float2.48%EarningsMay 23/a
Analyst Recom2.14Target Price43.89
Avg Volume386.41K52W Range19.63 - 41.80
StepStone Group, Inc. is a private markets investment firm. It focuses on providing customized investment solutions and advisory and data services to clients. The firm serves public and private defined benefit and defined contribution pension funds, sovereign wealth funds and insurance companies, prominent endowments, foundations, family offices and private wealth clients, which include high-net-worth and mass affluent individuals. The company was founded by Monte M. Brem, Jose A. Fernandez, Steve R. Mitchell, Thomas Porter Keck, and Robert A. Waldo in January 2007 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keck ThomasDirectorFeb 26 '24Sale35.473,694131,026200,750Feb 27 07:21 PM
Keck ThomasDirectorFeb 23 '24Sale35.4753,4031,894,204204,444Feb 27 07:21 PM
Keck ThomasDirectorFeb 22 '24Sale35.6848,6621,736,260257,847Feb 22 07:05 PM
Keathley AnthonyChief Accounting OfficerFeb 22 '24Sale35.7046916,7433,183Feb 22 07:11 PM
Keck ThomasDirectorFeb 21 '24Sale35.1024,241850,859306,509Feb 22 07:05 PM
AILE - iLearningEngines Inc. - Stock Price Chart
CompanyiLearningEngines Inc.
IndustrySoftware - Infrastructure
Market Cap68.62MEPS (ttm)-0.80
P/E-EPS this Y-290.00%
Forward P/E27.44EPS next Y210.26%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1276.09%
Dividend-Sales Q/Q-
Insider Own84.01%Inst Own5.22%
Insider Trans0.00%Inst Trans1.37%
Short Float1.23%EarningsMay 16/a
Analyst Recom1.00Target Price19.50
Avg Volume36.35K52W Range4.50 - 20.00
iLearningEngines, Inc. engages in the provision of artificial intelligence automation solutions. It operates at the intersection of three large and growing markets: global artificial intelligence, global e-learning and hyper automation. The company is headquartered in Bethesda, MD.
SONN - Sonnet BioTherapeutics Holdings Inc - Stock Price Chart
CompanySonnet BioTherapeutics Holdings Inc
Market Cap5.13MEPS (ttm)-5.28
P/E-EPS this Y88.04%
Forward P/E-EPS next Y-16.13%
PEG-EPS past 5Y74.20%
P/S57.02EPS next 5Y-
P/B1.68EPS Q/Q101.05%
Dividend-Sales Q/Q-100.00%
Insider Own9.27%Inst Own2.04%
Insider Trans0.00%Inst Trans7.93%
Short Float14.48%EarningsMay 14/a
Analyst Recom1.00Target Price5.33
Avg Volume98.13K52W Range1.08 - 26.40
Today 08:00AM Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting (GlobeNewswire)
May-22-24 07:00AM Sonnet BioTherapeutics Announces Review of Strategic Alternatives (ACCESSWIRE) +5.45%
May-20-24 09:15AM Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target (ACCESSWIRE) -5.43%
May-15-24 09:53AM SONN Stock Earnings: Sonnet BioTherapeutics Misses EPS for Q2 2024 (InvestorPlace)
May-14-24 04:15PM Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update (ACCESSWIRE)
May-06-24 07:00AM Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference (ACCESSWIRE)
May-03-24 09:00AM Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference (Newsfile)
Mar-19-24 07:30AM Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting (ACCESSWIRE)
Mar-11-24 07:30AM Sonnet BioTherapeutics Announces Early Safety Data from the Company's Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study's Initial Pre-Specified Objective (ACCESSWIRE) +11.89%
Feb-29-24 04:05PM Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers (ACCESSWIRE) +10.67%
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dexter SusanChief Technical OfficerJun 14 '23Buy0.7010,0007,00033,667Jun 15 04:15 PM
Dyrness Albert D.DirectorMay 30 '23Buy0.4723,25510,88328,962May 31 08:30 AM